Evidence map›Paper›PMID 26121175›Full record

ArticlePsychological trauma : theory, research, practice and policy2016

Treatment initiation and dropout from prolonged exposure and cognitive processing therapy in a VA outpatient clinic.

Shannon M Kehle-Forbes, Laura A Meis, Michele R Spoont, Melissa A Polusny

4 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in Psychological trauma : theory, research, practice and policy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 125 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed, 5 pooled it
24.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04617769 nacompletednot on this mapstarted 2021, after this paper: background citation

Effects of Antagonistic Actions in Response to Trauma Exposure

TypeinterventionalSponsorUniversity of Texas at AustinRan2021 to 2023Enrolled74ConditionsPost Traumatic Stress DisorderArmsPsychoeducation, Exposure
NCT05663151 narecruitingnot on this mapstarted 2024, after this paper: background citation

Mechanisms Underlying the Efficacy of Prolonged Exposure

TypeinterventionalSponsorVA Boston Healthcare SystemRan2024 to 2027Enrolled50ConditionsPosttraumatic Stress DisorderArmsProlonged Exposure Therapy for Posttraumatic Stress Disorder
NCT05788302 narecruitingnot on this mapstarted 2023, after this paper: background citation

Mechanisms Underlying Efficacy of Prolonged Exposure

TypeinterventionalSponsorMassachusetts General HospitalRan2023 to 2027Enrolled50ConditionsPost Traumatic Stress DisorderArmsProlonged Exposure
NCT06740487 narecruitingnot on this mapstarted 2025, after this paper: background citation

Advanced Wireless Augmented Reality-Enhanced Exposure Therapy for Posttraumatic Stress Disorder

TypeinterventionalSponsorWayne State UniversityRan2025 to 2027Enrolled40ConditionsPTSD, Post Traumatic Stress DisorderArmsTraditional Exposure Therapy (ET) Treatment, Stepwise Augmented Reality (AR) Component with Traditional Exposure Treatment for Nonresponders
3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 5 syntheses or guidelines pooled it, 315 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. MassedPsychological medicine · 2023
    Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shannon M Kehle-ForbesCenter for Chronic Disease Outcomes Research, Minneapolis VA Healthcare System.
Laura A MeisCenter for Chronic Disease Outcomes Research, Minneapolis VA Healthcare System.
Michele R SpoontCenter for Chronic Disease Outcomes Research, Minneapolis VA Healthcare System.
Melissa A PolusnyCenter for Chronic Disease Outcomes Research, Minneapolis VA Healthcare System.ORCID 0000-0002-4932-305X
Minneapolis VA Health Care System · US

Funding

HSRD VA CDA 09-020
6 · The paper itself

Abstract

Emerging data suggest that few veterans are initiating prolonged exposure (PE) and cognitive processing therapy (CPT) and dropout levels are high among those who do start the therapies. The goal of this study was to use a large sample of veterans seen in routine clinical care to 1) report the percent of eligible and referred veterans who (a) initiated PE/CPT, (b) dropped out of PE/CPT, (c) were early PE/CPT dropouts, 2) examine predictors of PE/CPT initiation, and 3) examine predictors of early and late PE/CPT dropout. We extracted data from the medical records of 427 veterans who were offered PE/CPT following an intake at a Veterans Health Administration (VHA) PTSD Clinical Team. Eighty-two percent (n = 351) of veterans initiated treatment by attending Session 1 of PE/CPT; among those veterans, 38.5% (n = 135) dropped out of treatment. About one quarter of veterans who dropped out were categorized as early dropouts (dropout before Session 3). No significant predictors of initiation were identified. Age was a significant predictor of treatment dropout; younger veterans were more likely to drop out of treatment than older veterans. Therapy type was also a significant predictor of dropout; veterans receiving PE were more likely to drop out late than veterans receiving CPT. Findings demonstrate that dropout from PE/CPT is a serious problem and highlight the need for additional research that can guide the development of interventions to improve PE/CPT engagement and adherence.

Indexed as

AdultAge FactorsAmbulatory Care FacilitiesCognitive Behavioral TherapyFemaleHumansImplosive TherapyMaleMiddle AgedOutpatientsPatient DropoutsSex FactorsTelemedicineTreatment OutcomeUnited StatesUnited States Department of Veterans Affairs

Identifiers

PMID26121175
PMCPMC9873270
OpenAlexW1900041560

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.